We found 153 records for "Financial"

Articles

Repairing the disconnect in medical technology

19th June 2014

 Repairing the disconnect in medical technology Articles

Powerful external forces are disrupting the traditional strategies of medical technology leaders as companies face greater economic pressures, a reformed health care system, new hospital and physician alignments, and new...

Read more

The trend to blend: M&A in pharma - Are you ready?

17th June 2014

 The trend to blend: M&A in pharma - Are you ready?Articles

Paul Gershlick and Laura Barrell examine the recent surge in mergers and acquisitions, and look at what small to medium sized firms can do to make themselves more attractive to...

Read more

US patient assistance programmes - a critique

6th June 2014

 US patient assistance programmes - a critiqueArticles

Financial support given to patients is receiving more demand in the US, totalling an estimated $15 billion, but are patient assistance programmes good for either patients or pharmaceutical companies, and...

Read more

Pharma gets social: Pfizer and AstraZeneca in pharma’s biggest ever social media explosion?

15th May 2014

 Pharma gets social: Pfizer and AstraZeneca in pharma’s biggest ever social media explosion?Articles

Daniel Ghinn explores the buzz of social media around the Pfizer / AstraZeneca news story. The huge volume of social media activity around the story, as it has been breaking,...

Read more

News

Allergan cuts workforce as part of restructure

22nd July 2014

 Allergan cuts workforce as part of restructureNews

Allergan has announced that about 13 per cent of its workforce will go as part of a restructure in the second half of 2014.About 1,500 employees – a higher number...

Read more

AbbVie and Shire merger agreed

21st July 2014

 AbbVie and Shire merger agreedNews

AbbVie and Shire have announced that their long-awaited merger is to go ahead, following AbbVie's fifth takeover offer.The deal, which the companies announced on Friday, is worth £32 billion ($53 billion).  The...

Read more

Wales launches its own life sciences hub

17th July 2014

 Wales launches its own life sciences hubNews

A new initiative has been launched to help the life sciences sector flourish in Wales, with a £100 million investment fund to boost innovation and growth.The £100 million Life Sciences...

Read more

US lawmakers aim to block tax inversion deals

16th July 2014

 US lawmakers aim to block tax inversion dealsNews

US companies could be blocked from reducing their corporate tax liabilities by merging with overseas companies - a process known as tax inversion - if President Obama has his way.The...

Read more

White Papers

Redefining Market Access - Effective Value Engagement

3rd December 2013

 Redefining Market Access - Effective Value EngagementWhite Papers

Phenestra's latest white paper highlights the challenges in market access and reimbursement for every company involved in developing new and innovative drugs.Today, every pharmaceutical company has the patient at the...

Read more

Audio & Video

Webinar: 9 July - The future of UK pharma

The global pharmaceutical market passes a significant milestone in 2014: reaching one trillion US dollars in total value. IMS Health forecasts the global market will see a compound average growth...

Read more

Events

3rd Pharma Packaging and Labelling Forum

11th September 2014 - 12th September 2014

3rd Pharma Packaging and Labelling Forum

With current regulatory strictness and non-easing economical atmosphere pharma companies have an intensifying need to focus on complying with restrictions while keeping their efficiency & cost-cutting initiatives. With new...

Read more

Big Data in Pharma

16th September 2014 - 19th September 2014

Big Data in Pharma

To cut through the Big Data hype, and yield actionable, measurable insights to transform the pharma and healthcare sector requires leveraging the experiences of the leading pharma executives and top...

Read more

Big Data in Pharma

23rd September 2014

Big Data in Pharma

The volume of data is exploding, challenging drug makers’ ability to transform this data into additional revenue. But companies who can exploit big data and analytics have the potential to...

Read more

Orphan Drugs, Collaborations and Market Access Congress

29th September 2014 - 30th September 2014

Orphan Drugs, Collaborations and Market Access Congress

Stream 1 - Market Access - Partnerships, VC Investment & Strategy Stream 2 - Orphan Drugs Case Studies Stream 3 - Emerging Therapies & Technology Uses/Genome Mapping & Screening Technologies Stream 4 -...

Read more

Press Releases

Aqurance launches Market Research & Predictive Analytics Services

3rd July 2014

Aqurance launches Market Research & Predictive Analytics Services

Athens, GR, July 02, 2014: Aqurance, a dynamic startup that specializes inLife Sciences consulting and technology implementation services, has recently announced the launch of a new business department, the Market...

Read more